4

Back to all posts

Fedex Awards More Than $250,000 to Winners of the Annual Fedex Small Business Grant Contest
Dr. Ginger Johnson, RenoVō, Equine Regenerative Medicine, Stem Cell Therapy, Entrepreneurial Leadership
FedEx 2021 Grand Prize Small Business Grant Contest

MEMPHIS, Tenn.–(BUSINESS WIRE)–FedEx Corp. (NYSE: FDX) announced today that Equine Amnio Solutions – a Texas based veterinary pharmaceutical company, is the grand prize winner of its ninth annual FedEx Small Business Grant Contest. Equine Amnio Solutions (EAS) will receive a $50,000 grant, plus $7,500 in FedEx Office® print and business services to use in the company’s mission to provide innovative products to maximize the health and performance of horses across all breeds and athletic disciplines.

“This has been an extraordinarily tough year on small business owners, which is why it’s so critical that FedEx continues to champion and support these entrepreneurs,” said Jenny Robertson, senior vice president Integrated Marketing and Communications at FedEx. “We love to see small businesses thrive, and we are incredibly proud when we can help play a role in that success.”

The Equine Amnio Solutions story began thanks to the co-founders’ love of horses, via their daughter. Ginger and Ray Johnson are longtime entrepreneurs who brought EAS to market because they have a passion for improving the lives of these animals and the humans who care for them. They plan to use the funds for ongoing clinical studies in tandem with their research and development program to launch a new product for canine use.

“We are honored to be named the 2021 FedEx Small Business Grant Contest Grand Prize Winner,” said Ginger Johnson, Equine Amnio Solutions co-founder. “RenoVō® is an advancement in regenerative medicine for equine use, and we are thrilled at the thought of helping more animals stay healthy.”

FedEx Grant Winner Ginger Johnson
Grand Prize Winner Receives $50,000, plus $7,500 in FedEx Office print services
Equine Amnio Solutions is the market leader in the distribution of next-generation regenerative veterinary products to maximize the health and performance of horses across all breeds and athletic disciplines. One of these products, RenoVō®, has been used in over 4,000 horses and is considered a game-changing equine tissue therapy by owners and veterinarians.

You may want to read these articles

RenoVō® CASE STUDY: Puncture Wound

RenoVō® CASE STUDY: Puncture Wound

Case presentation - June 9, 2022: A three-year-old Quarter Horse filly backed into the catch for the stall door and punctured herself, creating a large, deep wound on her left thigh. The wound was sutured with internal and external stiches at clinic, however the...

RenoVō® CASE STUDY: Superficial Digital Flexor Tendon (RH)

RenoVō® CASE STUDY: Superficial Digital Flexor Tendon (RH)

Case presentation - June 9, 2016: A 9 year old Warmblood jumping horse presented with a superficial digital flexor tendon injury of the right hind leg. The horse was treated with stem cell injections. After 10 months of rest and rehabilitation, the horse slowly went...

RenoVō® CASE STUDY: Summer Sore

RenoVō® CASE STUDY: Summer Sore

Case presentation - June 17, 2022: A 19-year-old Red Horse presented to Topgun Veterinarian Service, Rock Hill, SC, with a large Summer Sore on the commissure of the right side of the mouth. The horse was treated orally with Ivermectin and topically with Ivermectin...